Glucose-insulin-potassium therapy in the era of coronary revascularization

Cardiology in Review

Volumn 13, Issue 5, 2005, Pages 266-270

  Leos, Cara L ^a   Griego, Jennifer E ^a   Anderson, Joe R ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Acute myocardial infarction; Coronary revascularization; Glucose insulin potassium

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; INSULIN; MORPHINE; POTASSIUM;

ACUTE HEART INFARCTION; AEROBIC METABOLISM; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ENERGY YIELD; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTHESIS; META ANALYSIS; MORBIDITY; MORTALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARDIOPLEGIC SOLUTIONS; DEPRESSION; DIABETES MELLITUS; DRUG COMBINATIONS; GLUCOSE; HUMANS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; POTASSIUM; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 23944494567     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000175287.38905.14     Document Type: Article

References (14)

1. Sodi-Pallares D, Testelli MR, Fishleder BL, et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol. 1962;9:166-181.
2. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994;343:155-158.
3. Antman EB, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation. 2004;110:588-636.
4. Allard MF, Stanley WA, Lopaschuk GD. Metabolic effects of glucose-insulin-potassium on the heart. Heart and Metabolism. Available at: http://www.heartandmetabolism.org. Accessed May 11, 2005.
5. Das UN. Insulin: an endogenous cardioprotector. Curr Opin Crit Care. 2003;9:375-383.
6. Zhang L, Li YH, Zhang HY, et al. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction. Eur J Clin Invest. 2005;35:164-170.
7. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
8. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latino-america) Collaborative Group. Circulation. 1998;98:2227-2234.
9. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-446.
10. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin- potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999;13:191-200.
11. Van der Horst I, Zijlstra F, van't Hof A, et al. Glucose-insulin- potassium infusion in patients treated with primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2003;42:784-791.
12. GIPS-II. The end of GIK therapy in STEMI patients. Presented at the American College of Cardiology 2005 Scientific Sessions; Orlando, FL; March 2005. Available at: http://www.theheart.org/printArticle. do?primaryKey=401405. Accessed March 10, 2005.
13. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
14. DIGAMI Study Group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.